Publication: Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study
2
Issued Date
2021-09-01
Resource Type
ISSN
19326203
Other identifier(s)
2-s2.0-85114245781
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS ONE. Vol.16, No.9 September (2021)
Suggested Citation
Dararat Eksombatchai, Thananya Wongsinin, Thanyakamol Phongnarudech, Kanin Thammavaranucupt, Naparat Amornputtisathaporn, Somnuek Sungkanuparph Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study. PLoS ONE. Vol.16, No.9 September (2021). doi:10.1371/journal.pone.0257040 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/79317
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study
Other Contributor(s)
Abstract
Objectives To study abnormality of spirometry, six-minute walk distance, and chest radiograph among patients recovered from Coronavirus Disease 2019 (COVID-19). Methods and study design A prospective cohort study was conducted in 87 COVID-19 confirmed cases who recovered and discharged from a medical school hospital in Thailand. At the follow-up visit on day 60 after onset of symptoms, patients underwent an evaluation by spirometry (FVC, FEV1, FEV1/FVC, FEF25-75, and PEF), a six-minute-walk test (6MWT), and a chest radiograph. Results There were 35 men and 52 women, with a mean age of 39.6±11.8 years and the mean body mass index (BMI) was 23.8±4.3 kg/m2. Of all, 45 cases had mild symptoms; 35 had nonsevere pneumonia, and 7 had severe pneumonia. Abnormality in spirometry was observed in 15 cases (17.2%), with 8% of restrictive defect and 9.2% of obstructive defect. Among the patients with an abnormal spirometry, the majority of the cases were in the severe pneumonia group (71.4%), compared with 15.6% in the non-severe pneumonia group, and 10.2% in the mild symptom group (p = 0.001). The mean six-minute-walk distance (6MWD) in the mild symptom and non-severe pneumonia groups was 538±56.8 and 527.5±53.5 meters, respectively. Although the severe pneumonia group tended to have a shorter mean 6-min walking distance, but this was not statistically significant (p = 0.118). Twelve patients (13.8%) had abnormal chest radiographs that showed residual fibrosis. This abnormality was more common in the severe pneumonia group (85.7%) and in others (7.5%) (p<0.001). Conclusions Abnormal spirometry was noted in 17.2% of COVID-19 survivors with both restrictive and obstructive defects. Severe COVID-19 pneumonia patients had higher prevalence rates of abnormal spirometry and residual fibrosis on the chest radiographs when compared to patients in the mild symptom and non-severe pneumonia groups.